Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Why Big Pharma Wants to Give This Baby Biotech Half a Billion Dollars

Inovio Pharmaceuticals Inc. (NYSE: INO) - a synthetic-vaccine player we recommended back on Feb. 1 - yesterday announced a two-product partnership deal with Swiss pharmaceutical giant Roche Holdings AG (OTC ADR: RHHBY) that could net the tiny biotech as much as $422.5 million. Shares of the Blue Bell, Pa.-based biotech jumped as much as 32% in the pre-market, and then surged 14.86% for the day. The shares are currently up 259% from where we recommended them seven months ago, and have been as high as 351%.

  1. buffalokandravi@aol.com | September 14, 2013

    Energy, Enterprise, = Synodron = safety!

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK